Mayo Clinic launched imaging solution to enable digital pathology across the enterprise
On Jun. 25, 2020, in support of Mayo Clinic’s digital health and practice transformation initiatives, the Mayo Clinic…
Takeda received FDA approval to manufacture ENTYVIO (vedolizumab) drug substance at Brooklyn Park, Minnesota facility
On Jun. 23, 2020, Takeda Pharmaceutical announced that the FDA had approved the company’s submission for its biologics…
ViralClear opened enrollment with first patient dosing in phase II human trial of anti-viral MMPD oral solution for treatment of COVID-19
On Jun. 17, 2020, BioSig Technologies, and its subsidiary, ViralClear, announced that it had commenced patient enrollment with…
Thermo Fisher Scientific response to COVID-19 expanded to include new serology test
On May 13, 2020, Thermo Fisher Scientific announced it will expand its response to the COVID-19 pandemic by…
3M and Ford begin shipping newly designed powered air-purifying respirators for health care workers fighting COVID-19
On May 6, 2020, 3M and Ford announced that newly designed powered air-purifying respirators (PAPRs), developed are on…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics
Mayo Clinic received $26 million from BARDA for COVID-19 convalescent plasma expanded access program
On May 4, 2020, Mayo Clinic was awarded a $26 million contract from the Biomedical Advanced Research and…
US Dept of Veterans Affairs participated in drug, plasma trials in fight against COVID-19
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
CHF Solutions shipped Aquadex product to COVID-19 specialty center in Minnesota
On May 1, 2020, CHF Solutions announced that it has shipped Aquadex product to a specialty care center…
3M completed sale of its drug delivery business
On May 1, 2020, 3M announced it had completed the sale of substantially all of its drug delivery…
ViralClear submits investigational New Drug Application to FDA for phase II clinical trials for merimepodib
On Apr. 24, 2020, BioSig Technologies announced that subsidiary ViralClear had submitted an Investigational New Drug (IND) application…
Biotechnology | COVID-19 | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics
Mayo Clinic partnered with state of Minnesota, University of Minnesota on breakthrough COVID-19 initiative
On Apr. 23, 2020, the Mayo Clinic, Minnesota Department of Health and University of Minnesota announced a breakthrough…
Mayo Clinic prepared to commenced phase II FDA clinical trial for treatment of COVID-19 with Vicromax
On Apr. 16, 2020, BioSig Technologies announced that its subsidiary ViralClear Pharmaceuticals, had updated its clinical development program…
OpGen subsidiary Ares Genetics demonstrated feasibility and next generation sequencing based antibiotic susceptibility testing in multi-center study
On Apr. 16, 2020, OpGen announced that a study on the feasibility and potential of antibiotic susceptibility testing…
FDA authorized first-of-its-kind low-cost ventilator developed by University of Minnesota
On Apr. 15, 2020, the U.S. Food and Drug Administration (FDA) authorized the production and use of a…
Mayo Clinic Laboratories launched serology testing in support of COVID-19 response
On Apr. 13, 2020, a new serology test from Mayo Clinic Laboratories that is used to identify the…
3M and White House announced plan to import 166.5 million additional respirators into the U.S. over the next three months
On Apr. 6, 2020, 3M and the White House announced a plan to import 166.5 million respirators over…
University of Minnesota Twin Cities designed respirator mask prototypes from filter technology
On Apr. 6, 2020, to address the need for N95 masks, an interdisciplinary research team at the University…
3M partnered with Cummins to increase production of filters for powered air purifying respirators
On Apr. 6, 2020, 3M announced a partnership with Cummins to increase the production of high efficiency particulate…
3M response to Defense Production Act Order
On Apr. 3, 2020, 3M announced that the Administration formally invoked the Defense Production Act to require 3M…
Mayo Clinic named national site for Convalescent Plasma Expanded Access Program
On Apr. 3, 2020, the FDA announced that the Mayo Clinic Mayo Clinic will be the lead institution…
University of Minnesota created on-site testing facility for COVID-19
On Apr. 3, 2020, the University of Minnesota announced it had created the stateï¾’s fourth on-site testing facility…
Mayo Clinic in Florida expanded specimen testing and processing capabilities for COVID-19
On Mar. 31, 2020, Mayo Clinic in Florida announced it had significantly ramped up efforts to process and…
University of Minnesota researchers orchestrated state’s fastest on-site testing for COVID-19
On Mar. 31, 2020, the University of Minnesota announced that the Medical School transformed two research buildings to…
Medtronic shared ventilation design specifications to accelerate efforts to increase global ventilator production
On Mar. 30, 2020 Medtronic announced it was publicly sharing the design specifications for the Puritan Bennett 560…
University of Minnesota researchers revealed how the novel coronavirus binds to human cells
On Mar. 30, 2020, researchers from the University of Minnesota broke new ground in understanding how SARS-CoV-2, the…
Medtronic launched new solutions to help monitor patients for COVID-19
On Mar. 27, 2020, Medtronic announced its Medtronic Care Management Services (MCMS) business had launched two new solutions…
COVID-19 will likely lead to US drug shortages
On Mar. 27, 2020, researchers at the University of Minnesota reported that the COVID-19 pandemic stands a good…
Mayo’s 3D Anatomic Modeling Lab printed model of virus that causes COVID-19
On Mar. 24, 2020, to help in educating the public and in the hope of better conveying the…
3M partnered with Ford to help further accelerate COVID-19 response
On Mar. 24, 2020, 3M and Ford Motor announced a partnership to increase the production of 3M’s powered…
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…